Dr. Maheshwari is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
421 Portage Trl
Cuyahoga Falls, OH 44221Phone+1 330-331-4466Fax+1 330-331-7478
Summary
- Secondary prevention of kidney stones,
Clinical Expertise
- Hypertension, Acute renal failure, Nephrolithiasis, Continuous renal replacement therapy, Peritoneal dialysis, Hemodialysis, Glomerulonephritis, Electrolyte disorders
Education & Training
- University of Alabama Medical CenterFellowship, Nephrology, 2015 - 2017
- University of Illinois College of Medicine at PeoriaResidency, Internal Medicine, 2009 - 2012
- Bangalore Medical CollegeClass of 2007
Certifications & Licensure
- OH State Medical License 2017 - 2026
- AL State Medical License 2015 - 2017
- IL State Medical License 2009 - 2017
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Publications & Presentations
PubMed
- Chronic massive pneumoperitoneum.Rajat Maheshwari, Sushilkumar K. Sonavane, Eric Wallace
Kidney International. 2016-12-01
Abstracts/Posters
- Effect of Distance and Time to a Home Dialysis Unit on Home Dialysis UtilizationR Maheshwari, N Chaudhary, R Griffin, E Wallace (, ASN Kidney week, 1/1/2016
- Tuberculous Peritonitis: A Cautionary Tale of "Negative" ResultsR Maheshwari, G Jain, C. Alexandra Hanna, E Wallace, NKF (The National Kidney Foundation), Boston, MA, 1/1/2016
- HIV induced thrombotic microangiopathy - A different approach to treatmentN Sharma MD, N Douyon MD, R Maheshwari MD, S Pinto MD, Society of Hospital Medicine (SHM), MD, 1/1/2014
- Join now to see all
Lectures
- Journal Club Ferric Citrate Reduces use of Iv Iron and ESA use in ESRD1/1/2016
- Senior CPC A patient with TMA secondary to MCTD1/1/2012
- Journal Club Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction1/1/2012
Professional Memberships
- Member
- Member
Other Languages
- Hindi, Kannada
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: